Pisces Plus (DW286 C)
510(k) K020183
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK020183 | Date13 Mar 2002 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- EJH
- Device class
- Class II
- Regulation
- 21 CFR Part 872.3710
- Advisory committee
- Dental
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 6 Oct 2026
Pisces Plus (DW286 C) is a base metal alloy used by dental professionals for the fabrication of dental restorations. It is intended for use in creating onlays, partial crowns, telescope crowns, conus crowns, posts, short and long span bridges, and PFM crowns.
The device is supplied by Ivoclar Vivadent, Inc. and is classified as a Class II medical device under FDA regulation 872.3710. It received traditional 510(k) clearance (K020183) on March 13, 2002, and is substantially equivalent to a legally marketed predicate device.
Other devices from Ivoclar Vivadent, Inc.
Questions
AI-generated answers, 6 Oct 2026
What is Pisces Plus (DW286 C) used for?
Pisces Plus (DW286 C) is a base metal alloy used by dental professionals to fabricate dental restorations such as onlays, partial crowns, telescope crowns, conus crowns, posts, short and long span bridges, and PFM crowns. It is intended for use in creating these specific types of dental prosthetics.
How is Pisces Plus (DW286 C) supplied and what is its classification?
Pisces Plus (DW286 C) is supplied by Ivoclar Vivadent, Inc. and is classified as a Class II medical device under FDA regulation 872.3710. It is provided as a dental alloy material for use in restoration fabrication.
What regulatory clearance does Pisces Plus (DW286 C) have?
Pisces Plus (DW286 C) received traditional 510(k) clearance (K020183) from the FDA on March 13, 2002, and is substantially equivalent to a legally marketed predicate device. This clearance allows it to be legally marketed in the United States for its intended use.